News
An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded ...
Blue Yonder unveils five domain-specific AI agents at ICON 2025, culminating CEO Duncan Angove's three-year, $2 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results